Physician profile

Christopher Thomas Huhta

Pulmonary Disease · Lansing, MI

NPI 1104859032

$12,664.23

in general payments reported to CMS, 2019-2025

31 companies · $7,374 in 2025

The $7,374 reported for 2025 was more than what 91% of Pulmonary Disease providers received nationally (typical 2025 total: $500).

See the full distribution for Pulmonary Disease

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Education$4,094.99
Food and Beverage$3,188.46
Travel and Lodging$2,048.46
Consulting Fee$400.00

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Intuitive Surgical, INC. $6,048.46 2025
Astrazeneca Pharmaceuticals LP $1,804.63 2019-2025 Fasenra, Tezspire, Airsupra
Boehringer Ingelheim Pharmaceuticals, INC. $1,038.51 2019-2025 Ofev, Spiriva Respimat, Stiolto Respimat
Grifols USA, LLC $593.89 2019-2025 Prolastin-C Liquid, Xembify
Glaxosmithkline, LLC. $568.11 2019-2025 Nucala, Trelegy Ellipta, Arexvy
Genzyme Corporation $435.72 2019-2025
Actelion Pharmaceuticals US, INC. $423.55 2020-2025 Opsumit, Uptravi
Bayer Healthcare Pharmaceuticals INC. $422.27 2023-2024
Regeneron Healthcare Solutions, INC. $306.37 2019-2025 Dupixent
Mylan Specialty L.P. $237.87 2019-2024 Yupelri
Amgen INC. $86.28 2022-2025 Tezspire
Merck Sharp & Dohme LLC $72.78 2019-2025 Keytruda, Winrevair
Insmed, INC. $71.52 2025 Arikayce, Brinsupri
Sunovion Pharmaceuticals INC. $62.68 2019
Philips North America LLC $62.20 2024-2025 Vest Therapy Und, (8874) Incourage
Show all 31 companies
CompanyGeneral paymentsYearsTop products
Viatris Specialty LLC $58.98 2025 Yupelri
Verona Pharma, INC. $43.46 2025 Ohtuvayre
Genentech USA, INC. $42.57 2019-2021
3b Medical, INC. $39.12 2025 Luna
Jazz Pharmaceuticals INC. $38.09 2021
Ethicon INC. $29.96 2025 Monarch Platform
Bard Peripheral Vascular, INC. $25.11 2021
Teva Pharmaceuticals USA, INC. $24.74 2020-2022
United Therapeutics Corporation $22.14 2021
Resmed Corp $20.71 2019
Alexion Pharmaceuticals, INC. $15.38 2023 Ultomiris
Pfizer INC. $15.37 2025
Phadia US INC. $14.91 2024 Immunocap
Shire North American Group INC $13.62 2019
Covidien LP $13.38 2020
Electromed, INC. $11.85 2019

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Christopher Thomas Huhta

$12,664.23

in general payments reported 2019-2025

Years
2019-2025
Top company
Intuitive Surgical, INC.
Context
The $7,374 reported for 2025 was more than what 91% of Pulmonary Disease providers received nationally (typical 2025 total: $500).

https://glasscript.com/doctor/276483/christopher-thomas-huhta

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.